Pearson JW - Search Results

1

Restoration of interferon alpha potentiation of a recombinant ricin A chain immunotoxin following cytoreduction of xenografts of advanced ovarian tumors.

Pearson JW, Fogler WE, Volker K, Riggs CW, Gruys E, Groves ES, Wiltrout RH, Longo DL. Pearson JW, et al. J Natl Cancer Inst. 1993 Jun 2;85(11):907-12. doi: 10.1093/jnci/85.11.907. J Natl Cancer Inst. 1993. PMID: 8492319

2

Reversal of drug resistance in a human colon cancer xenograft expressing MDR1 complementary DNA by in vivo administration of MRK-16 monoclonal antibody.

Pearson JW, Fogler WE, Volker K, Usui N, Goldenberg SK, Gruys E, Riggs CW, Komschlies K, Wiltrout RH, Tsuruo T, et al. Pearson JW, et al. J Natl Cancer Inst. 1991 Oct 2;83(19):1386-91. doi: 10.1093/jnci/83.19.1386. J Natl Cancer Inst. 1991. PMID: 1681110

3

Enhanced therapeutic efficacy against an ovarian tumor xenograft of immunotoxins used in conjunction with recombinant alpha-interferon.

Pearson JW, Hedrick E, Fogler WE, Bull RL, Ferris DK, Riggs CW, Wiltrout RH, Sivam G, Morgan AC, Groves E, et al. Pearson JW, et al. Cancer Res. 1990 Oct 1;50(19):6379-88. Cancer Res. 1990. PMID: 2144790

4

Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.

Pearson JW, FitzGerald DJ, Willingham MC, Wiltrout RH, Pastan I, Longo DL. Pearson JW, et al. Cancer Res. 1989 Jul 1;49(13):3562-7. Cancer Res. 1989. PMID: 2499420

5

Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.

Pearson JW, Sivam G, Manger R, Wiltrout RH, Morgan AC Jr, Longo DL. Pearson JW, et al. Cancer Res. 1989 Sep 15;49(18):4990-5. Cancer Res. 1989. PMID: 2504482

6

Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.

Fogler WE, Pearson JW, Volker K, Ariyoshi K, Watabe H, Riggs CW, Wiltrout RH, Longo DL. Fogler WE, et al. Among authors: pearson jw. J Natl Cancer Inst. 1995 Jan 18;87(2):94-104. doi: 10.1093/jnci/87.2.94. J Natl Cancer Inst. 1995. PMID: 7707396

7

Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.

Rybak SM, Pearson JW, Fogler WE, Volker K, Spence SE, Newton DL, Mikulski SM, Ardelt W, Riggs CW, Kung HF, Longo DL. Rybak SM, et al. Among authors: pearson jw. J Natl Cancer Inst. 1996 Jun 5;88(11):747-53. doi: 10.1093/jnci/88.11.747. J Natl Cancer Inst. 1996. PMID: 8637029

8

Reversal of multidrug resistance in human colon cancer cells expressing the human MDR1 gene by liposomes in combination with monoclonal antibody or verapamil.

Sela S, Husain SR, Pearson JW, Longo DL, Rahman A. Sela S, et al. Among authors: pearson jw. J Natl Cancer Inst. 1995 Jan 18;87(2):123-8. doi: 10.1093/jnci/87.2.123. J Natl Cancer Inst. 1995. PMID: 7707383

9

Preclinical evaluation of bryostatin as an anticancer agent against several murine tumor cell lines: in vitro versus in vivo activity.

Hornung RL, Pearson JW, Beckwith M, Longo DL. Hornung RL, et al. Among authors: pearson jw. Cancer Res. 1992 Jan 1;52(1):101-7. Cancer Res. 1992. PMID: 1727368

10

Anti-tumor ribonuclease, combined with or conjugated to monoclonal antibody MRK16, overcomes multidrug resistance to vincristine in vitro and in vivo.

Newton D, Pearson J, Xue Y, Smith M, Fogler W, Mikulski S, Alvord W, Kung H, Long D, Rybak S. Newton D, et al. Int J Oncol. 1996 Jun;8(6):1095-104. doi: 10.3892/ijo.8.6.1095. Int J Oncol. 1996. PMID: 21544469

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters